DOP071 Tight control with adalimumab-based treatment is associated with improved quality of life outcomes in patients with moderate to severely active Crohn’s disease: data from CALM | Zendy

AI Assistant Blog Pricing

DOP071 Tight control with adalimumab-based treatment is associated with improved quality of life outcomes in patients with moderate to severely active Crohn’s disease: data from CALM

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.